Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1.

作者: Youchun Zeng , Nengbing Tao , Koong-Nah Chung , John E. Heuser , Douglas M. Lublin

DOI: 10.1074/JBC.M307722200

关键词:

摘要: The scavenger receptor CD36 binds a diverse array of ligands, including thrombospondin-1, oxidized low density lipoprotein (OxLDL), fatty acids, anionic phospholipids, and apoptotic cells. has been reported to be present in lipid rafts/caveolae, but little is known about the membrane trafficking this protein at baseline or following ligand binding. Here, we determined that expression Chinese hamster ovary (CHO) cells endogenous C32 led homogeneous distribution on plasma membrane, as judged by confocal fluorescence microscopy. This pattern was observed both anti-CD36 antibody staining live cell imaging CHO expressing chimeric CD36-green fluorescent construct. In contrast, caveolin-1 displayed its usual punctate surface distribution. Correspondingly, dual labeling showed essentially no overlap, neither immunofluorescence light microscopy nor immunogold electron Furthermore, isolation rafts sucrose gradient ultracentrifugation cold Triton X-100 lysates yielded caveolin-1, immunoprecipitates did not contain CD36. Binding Ox-LDL internalization OxLDL into endosomal structures transferrin co-internalized glycosyl-phosphatidylinositol-anchored decay accelerating factor, raft protein. caveolin-1-negative KB line sufficient for OxLDL-induced CD36, indicating required endocytic process. Taken together, these data demonstrate steady state, localized caveolae, binding leads endocytosis through pathway distinct from clathrin-mediated caveolin pathways.

参考文章(52)
C Marboe, L Chess, V D'Agati, D M Knowles, M Grimes, B Tolidjian, Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distributions including differential reactivity with vascular endothelium. Journal of Immunology. ,vol. 132, pp. 2170- 2173 ,(1984)
N N Tandon, R H Lipsky, W H Burgess, G A Jamieson, Isolation and characterization of platelet glycoprotein IV (CD36) Journal of Biological Chemistry. ,vol. 264, pp. 7570- 7575 ,(1989) , 10.1016/S0021-9258(18)83272-0
Kai Simons, Derek Toomre, Lipid rafts and signal transduction Nature Reviews Molecular Cell Biology. ,vol. 1, pp. 31- 39 ,(2000) , 10.1038/35036052
D. J. Anstee, T. Kinoshita, K. E. Coyne, W. Rosse, E. Scott Thompson, S. E. Hall, D. M. Lublin, T. Fujita, M. A. Arce, Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. Journal of Immunology. ,vol. 149, pp. 2906- 2913 ,(1992)
Lucas Pelkmans, Jürgen Kartenbeck, Ari Helenius, Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nature Cell Biology. ,vol. 3, pp. 473- 483 ,(2001) , 10.1038/35074539
Dennis J. Dietzen, W. Randall Hastings, Douglas M. Lublin, Caveolin Is Palmitoylated on Multiple Cysteine Residues Journal of Biological Chemistry. ,vol. 270, pp. 6838- 6842 ,(1995) , 10.1074/JBC.270.12.6838
Babak Razani, Jeffery A Engelman, Xiao Bo Wang, William Schubert, Xiao Lan Zhang, Carolyn B Marks, Frank Macaluso, Robert G Russell, Maomi Li, Richard G Pestell, Dolores Di Vizio, Harry Hou, Burkhard Kneitz, Guy Lagaud, George J Christ, Winfried Edelmann, Michael P Lisanti, None, Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities Journal of Biological Chemistry. ,vol. 276, pp. 38121- 38138 ,(2001) , 10.1074/JBC.M105408200
Christopher K. Glass, Joseph L. Witztum, Atherosclerosis: The Road Ahead Cell. ,vol. 104, pp. 503- 516 ,(2001) , 10.1016/S0092-8674(01)00238-0
G. Endemann, L.W. Stanton, K.S. Madden, C.M. Bryant, R.T. White, A.A. Protter, CD36 is a receptor for oxidized low density lipoprotein. Journal of Biological Chemistry. ,vol. 268, pp. 11811- 11816 ,(1993) , 10.1016/S0021-9258(19)50272-1